C07C 255/44
At least one of the singly-bound nitrogen atoms being acylated
Official title: at least one of the singly-bound nitrogen atoms being acylated
C07C255/44 (At least one of the singly-bound nitrogen atoms being acylated) appears on 96 US grants and 113 published applications in this corpus.
Search patents in C07C- Granted patents
- 96
- Published applications
- 113
- Assignees
- 91
- Inventors
- 391
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 2 |
| 2003 | 0 | 5 |
| 2004 | 3 | 9 |
| 2005 | 2 | 5 |
| 2006 | 3 | 8 |
| 2007 | 4 | 5 |
| 2008 | 7 | 8 |
| 2009 | 1 | 6 |
| 2010 | 5 | 4 |
| 2011 | 3 | 5 |
| 2012 | 4 | 8 |
| 2013 | 4 | 5 |
| 2014 | 8 | 4 |
| 2015 | 2 | 8 |
| 2016 | 6 | 4 |
| 2017 | 2 | 4 |
| 2018 | 3 | 3 |
| 2019 | 2 | 2 |
| 2020 | 0 | 2 |
| 2021 | 3 | 5 |
| 2022 | 2 | 0 |
| 2023 | 1 | 3 |
| 2024 | 2 | 4 |
| 2025 | 0 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds and methods of inhibiting bacterial chaperonin systems29 Sep 2026US 12,747,219 B2Arizona Board of Regents on Behalf of the University of Arizona
- HNQO1-activatable fluorescent probe for imaging cancer cells in-vitro and in-vivo16 Apr 2024US 11,957,766 B2Texas Tech University System
- Sphingosine kinase inhibitors23 Jan 2024US RE49,811 E1Apogee Biotechnology Corporation
- Alcohol derivatives as KV7 potassium channel openers10 Jan 2023US 11,548,849 B2H. Lundbeck A.S.
- SPAK kinase inhibitors as neuroprotective agents16 Aug 2022US 11,414,379 B2The United States Government as represented by the Department of Veterans Affairs
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Fto inhibitors5 Feb 2026US 2026/0035341 A1Rpxds Co., Ltd
- Compounds and methods for treating corona viruses23 Jan 2025US 2025/0025443 A1Clear Creek Bio, Inc.
- Alcohol derivatives as kv7 potassium channel openers3 Oct 2024US 2024/0327336 A1H. Lundbeck A.S.
- A new molecular scaffold for targeting hrpn1326 Sep 2024US 2024/0317732 A1The United States of America as represented by the Secretary, Department of Health and Human Service
Most cited
By later US patents
- Potent inducers of terminal differentiation and methods of use thereof95US 5,369,108 ASloan-Kettering Institute for Cancer Research · 1994
- Potent inducers of terminal differentiation and methods of use thereof91US 6,087,367 ASloan-Kettering Institute for Cancer Research · 2000
- Potent inducers of terminal differentiation and method of use thereof89US 5,700,811 ASloan-Kettering Institute for Cancer Research · 1997
- Stilbene compounds and pharmaceutical compositions containing them54US 5,674,906 AAjinomoto Co., Inc. · 1997
- Potent inducers of terminal differentiation and methods of use thereof50US 5,932,616 ASloan-Kettering Institute for Cancer Research · 1999